This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 326-B:16 · Licensure; All Applicants

326-B:16 Licensure; All Applicants. –

Copy link
I.

All applicants seeking licensure as an APRN, RN, or LPN shall:

Copy link
(a)

Submit a completed application and required fees.

Copy link
(b)

Have the ability to read and write in the English language.

Copy link
(c)

Report any pending criminal charges, criminal convictions, or plea arrangement in lieu of convictions.

Copy link
(d)

Have committed no acts or omissions which are grounds for disciplinary action as set forth in this chapter, or, if such acts have been committed and would be grounds for disciplinary action, the board has found, after investigation, that sufficient restitution has been made.

Copy link
(e)

Meet continuing competence requirements as defined in rules adopted under RSA 541-A.

Copy link
(f)

Meet other criteria as established by the board.

Copy link
II.

All applicants seeking licensure as an LNA shall:

Copy link
(a)

Submit a completed application and fees as established by the executive director.

Copy link
(b)

Have sufficient aptitude in the English language as defined in rules adopted under RSA 541-A.

Copy link
(c)

Report any pending criminal charges, criminal convictions, or plea arrangement in lieu of convictions.

Copy link
(d)

Have committed no acts or omissions which are grounds for disciplinary action as set forth in this chapter, or, if such acts have been committed and would be grounds for disciplinary action, the board has found, after investigation, that sufficient restitution has been made.

Copy link
(e)

Meet continuing competence requirements as defined in rules adopted under RSA 541-A.

Copy link
(f)

Meet other criteria as established by the board. Source. 2005, 293:1, eff. July 1, 2005 at 12:01 a.m. 2024, 120:1, eff. Sept. 1, 2024; 327:104, eff. July 1, 2024.

Copy link

Source note

Source. 2005, 293:1, eff. July 1, 2005 at 12:01 a.m. 2024, 120:1, eff. Sept. 1, 2024; 327:104, eff. July 1, 2024.

Source history

  • 2005, 293:1, eff. July 1, 2005 at 12:01 a.m
  • 2024, 120:1, eff. Sept. 1, 2024; 327:104, eff. July 1, 2024

Related materials

Bill relationships

  • 2026 HB1321 reference

    cian licensed under this chapter, a physician associate licensed under RSA 328-D acting within the scope of their practice, or an advanced practice registered nurse licensed under RSA 326-B acting within the scope of their practice. 329:56 Administration of Elective Intravenous Therapy. Elective intravenous therapy may only be administered by a physician licensed under this chapter, a physician associ

  • 2026 HB1796 reference · effective 2027-01-01

    rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic

  • 2026 HB1796-FN reference · effective 2027-01-01

    rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic

  • 2026 SB453 reference

    d by the commissioner or his designee shall be for a period not to exceed 2 years; except in any case where a licensed physician, advanced practice registered nurse licensed under RSA 326-B, or physician associate licensed under RSA 329-D documents a lasting medical necessity, in which case the waiver shall be for a period not to exceed 4 years. The applicant may reapply for the waiver before such period e

  • 2025 HB254 reference

    tions to be used in medical aid in dying: (1) A physician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider unde